Zuvog-M 0.3 Tablet PR

By Zuvog-M

Rx

10 Tablet PR in a Strip

Composition icon

Composition

Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Zuventus Healthcare Ltd icon

Manufacturer - Zuventus Healthcare Ltd

Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (E), Mumbai - 400 072.

Expires on or after icon

Expires on or after

October, 2025

About Zuvog-M 0.3 Tablet PR

Zuvog-M 0.3 Tablet PR is a medication classified as an anti-diabetic drug specifically designed to manage type 2 diabetes mellitus in adults. It plays a vital role in controlling blood sugar levels in individuals with diabetes. For optimal effectiveness, it is recommended to take Zuvog-M 0.3 Tablet PR with food consistently at the same time each day. The appropriate dosage will be determined by your doctor and may be adjusted based on your blood sugar levels over time.

Continuation of this medication is crucial, even if you are feeling well or if your blood sugar is under control. Abruptly stopping Zuvog-M 0.3 Tablet PR without medical guidance can result in elevated blood sugar levels, which can increase the risk of severe complications such as kidney damage, blindness, nerve issues, and limb amputation. It is important to remember that this tablet is just one element of a comprehensive treatment plan that should also encompass a healthy diet, regular exercise, and weight management as prescribed by your healthcare provider. Lifestyle modifications significantly contribute to diabetes control.

Side effects of Zuvog-M 0.3 Tablet PR may include temporary symptoms like nausea, changes in taste, reduced appetite, flatulence, stomach discomfort, diarrhea, and skin irritation. While these side effects typically diminish on their own, if they persist or cause concern, it is advisable to consult your doctor. Your healthcare provider may provide guidance on managing these effects or recommend treatment if they become bothersome.

Certain conditions may make individuals unsuitable for taking Zuvog-M 0.3 Tablet PR, such as type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease. Prior to initiating this medication, inform your doctor about any history of heart disease as well. Pregnant or breastfeeding individuals should also seek medical advice before using this medication. Regular monitoring of blood sugar levels is essential, and additional blood tests may be required to assess blood cell counts and liver function under the supervision of your doctor.


Benefits

Zuvog-M 0.3 Tablet PR, used in the treatment of Type 2 diabetes mellitus, offers various benefits for those managing high blood glucose levels. This medication works by slowing down the process of food breakdown in the intestine, thereby preventing a rapid spike in blood sugar levels after meals. Additionally, it aids in eliminating excess glucose through urine, contributing to a more controlled blood glucose level. Proper control of blood glucose is crucial in diabetes management, as it reduces the risk of serious complications such as kidney damage, eye problems, nerve issues, and even limb amputation.

For individuals with type 2 diabetes and existing cardiovascular disease, Zuvog-M 0.3 Tablet PR plays a key role in decreasing the risk of mortality from cardiovascular issues. It is essential to take this medication consistently alongside a balanced diet and regular exercise to ensure a healthy and normal life. By following the prescribed regimen, individuals can safeguard their future health and well-being. It is advisable to adhere to the prescribed treatment plan to reap the long-term benefits and protection that Zuvog-M 0.3 Tablet PR offers in managing diabetes effectively.


How to use the Zuvog-M 0.3 Tablet PR

To use Zuvog-M 0.3 Tablet PR properly, it is important to follow your doctor's instructions. Make sure to carefully read the label for specific directions before taking the tablet. It is recommended to take Voglihans M with food to help reduce the chances of any potential stomach discomfort. This medication should not be taken in larger or smaller amounts than prescribed by your doctor. If you have any questions or concerns about how to use Zuvog-M 0.3 Tablet PR, do not hesitate to consult with your healthcare provider for guidance.


Uses of Zuvog-M 0.3 Tablet PR

Zuvog-M 0.3 Tablet PR is primarily used for treating Type 2 diabetes mellitus. It helps in regulating blood sugar levels in people with this condition. This medication is important for managing diabetes effectively and should be taken as prescribed by a healthcare professional. By using Zuvog-M 0.3 Tablet PR, individuals with Type 2 diabetes can better control their blood sugar levels and improve their overall health.


What conditions Zuvog-M 0.3 Tablet PR treats?

Zuvog-M 0.3 Tablet PR is used in the treatment of type 2 diabetes mellitus. It helps to control high blood sugar levels by slowing down the breakdown of food in the intestine, reducing the rise in blood sugar after meals, and eliminating excess sugar through urine. Managing blood glucose levels is crucial in preventing complications such as kidney damage, eye problems, nerve issues, and limb loss. Additionally, this medication can lower the risk of cardiovascular disease-related deaths in individuals with type 2 diabetes and existing heart conditions. It is essential to take Zuvog-M 0.3 Tablet PR regularly, follow a healthy diet, and engage in physical activity to maintain a normal, healthy life.


Should you consult a doctor?

It is important to seek medical help if you experience persistent side effects like nausea, taste changes, loss of appetite, flatulence, stomach pain, diarrhea, or skin rash. If any of these side effects do not go away on their own or if they are concerning you, it is recommended to consult your doctor for guidance. Additionally, if you have type 1 diabetes mellitus, diabetic ketoacidosis, severe kidney or liver disease, or a history of heart disease, it is crucial to discuss with your doctor before taking Zuvog-M 0.3 Tablet PR. Pregnant or breastfeeding women should also seek medical advice before starting this medication. Monitoring of blood sugar levels, as well as regular blood tests to check blood cell counts and liver function, are essential, so follow your doctor's guidance closely. Take this medicine as prescribed and do not stop it abruptly without consulting your doctor, as it could lead to complications such as elevated blood sugar levels and associated risks like kidney damage, blindness, nerve problems, and limb loss. Remember, Zuvog-M 0.3 Tablet PR is just one part of a comprehensive treatment plan that should also include a healthy diet, regular exercise, and weight management tailored to your needs. Your doctor will determine the most appropriate dose for you based on your individual response and may adjust it as needed to optimize your diabetes management.


Side effects of Zuvog-M 0.3 Tablet PR

When taking Zuvog-M 0.3 Tablet PR, you may experience certain side effects. Most of these side effects do not need medical intervention and typically improve as your body gets used to the medication. However, it is essential to consult your doctor if the side effects persist or if you are concerned about them. Common side effects of Zuvog-M 0.3 Tablet PR include flatulence, diarrhea, abdominal pain, vomiting, and decreased appetite. If any of these side effects become bothersome or severe, seek medical advice for proper management.


Safety advice

scroll

liver

Limited information is available regarding the use of Zuvog-M 0.3 Tablet PR in patients with liver disease. It is crucial to consult your doctor before using this medication to ensure it is safe and appropriate for you.

scroll

kidney

Zuvog-M 0.3 Tablet PR should be used carefully in patients with kidney conditions. Adjusting the dosage may be necessary. Avoid using this medication in severe kidney disease cases. It's recommended to monitor kidney function regularly during treatment.

scroll

alcohol

It is unsafe to drink alcohol while taking Zuvog-M 0.3 Tablet PR.

scroll

driving

Zuvog-M 0.3 Tablet PR generally does not impact driving ability. Yet, there could be a risk of hypoglycemia when it is taken with certain diabetes medications, like sulfonylureas, insulin, and repaglinide.

scroll

pregnancy

Zuvog-M 0.3 Tablet PR may be unsafe during pregnancy based on limited human studies, with possible harm to the developing baby according to animal studies. Your doctor will evaluate benefits versus risks before prescribing. Please consult your doctor.

scroll

breastfeeding

Zuvog-M 0.3 Tablet PR is possibly unsafe while breastfeeding. Limited data shows it may enter breastmilk and harm the baby.


Consumption warning before consuming Zuvog-M 0.3 Tablet PR

Before consuming Zuvog-M 0.3 Tablet PR, it is important to note the following precautions. This medication is primarily used to manage type 2 diabetes mellitus in adults by regulating blood sugar levels. It is essential to take Zuvog-M 0.3 Tablet PR with food consistently at the same time each day as prescribed by your doctor to achieve optimal results. Even if you feel well, continuous use is necessary as stopping abruptly could lead to increased blood sugar levels, posing risks of kidney damage, blindness, nerve issues, and limb loss.

Aside from medication, a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management is crucial in managing diabetes effectively. While Zuvog-M 0.3 Tablet PR may cause temporary side effects like nausea, taste alterations, and stomach discomfort, consulting your doctor if these persist is advised. It is not recommended for individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver problems, or a history of heart disease. Pregnant or breastfeeding women should consult their healthcare provider before starting this medication. Regular monitoring of blood sugar levels and recommended blood tests are essential during the course of treatment.


What if you forgot to take Zuvog-M 0.3 Tablet PR?

If you forget to take a dose of Zuvog-M 0.3 Tablet PR, try to take it as soon as you remember. But if it's close to the time for your next dose, then just skip the missed dose and continue with your normal dosing schedule. Avoid taking a double dose to make up for the missed one.


Related lab tests

Related Lab Tests for Zuvog-M 0.3 Tablet PR include glucose fasting blood test, glucose postprandial blood test, and glycosylated hemoglobin test. These tests are important to monitor the effect of the medication on blood sugar levels. The glucose fasting blood test measures the amount of sugar in the blood after fasting for a certain period of time. The glucose postprandial blood test measures the blood sugar level after eating a meal. The glycosylated hemoglobin test gives an average of blood sugar levels over the past 2-3 months. These lab tests help healthcare providers assess the response to Zuvog-M 0.3 Tablet PR and make necessary adjustments to the treatment plan.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

210.15

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 11-Feb-2025